Fu-Shun Hsu

424 total citations
22 papers, 278 citations indexed

About

Fu-Shun Hsu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Fu-Shun Hsu has authored 22 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Fu-Shun Hsu's work include Bladder and Urothelial Cancer Treatments (5 papers), Phonocardiography and Auscultation Techniques (5 papers) and Respiratory and Cough-Related Research (4 papers). Fu-Shun Hsu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (5 papers), Phonocardiography and Auscultation Techniques (5 papers) and Respiratory and Cough-Related Research (4 papers). Fu-Shun Hsu collaborates with scholars based in Taiwan and United States. Fu-Shun Hsu's co-authors include Wen‐Chang Chang, Chun-Hung Su, Kuo‐How Huang, Wei‐Chou Lin, Kuan-Lin Kuo, Shing‐Hwa Liu, Hong‐Chiang Chang, Chung‐Sheng Shi, Po‐Ming Chow and Wen‐Yi Shau and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Cells.

In The Last Decade

Fu-Shun Hsu

18 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fu-Shun Hsu Taiwan 10 118 55 47 43 41 22 278
Chaoyan Wu China 10 162 1.4× 59 1.1× 18 0.4× 28 0.7× 39 1.0× 27 379
Jiayu Lv China 12 150 1.3× 46 0.8× 33 0.7× 41 1.0× 41 1.0× 37 407
Hanbin Lin China 11 140 1.2× 44 0.8× 44 0.9× 21 0.5× 31 0.8× 27 309
Zhipeng Du China 11 203 1.7× 49 0.9× 81 1.7× 45 1.0× 37 0.9× 20 440
Lin Feng China 7 123 1.0× 30 0.5× 85 1.8× 40 0.9× 22 0.5× 24 286
Xiaoqiang Geng China 11 196 1.7× 37 0.7× 45 1.0× 67 1.6× 20 0.5× 15 389
Jiang Xu China 12 303 2.6× 24 0.4× 59 1.3× 41 1.0× 51 1.2× 27 461

Countries citing papers authored by Fu-Shun Hsu

Since Specialization
Citations

This map shows the geographic impact of Fu-Shun Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu-Shun Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu-Shun Hsu more than expected).

Fields of papers citing papers by Fu-Shun Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fu-Shun Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu-Shun Hsu. The network helps show where Fu-Shun Hsu may publish in the future.

Co-authorship network of co-authors of Fu-Shun Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Fu-Shun Hsu. A scholar is included among the top collaborators of Fu-Shun Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fu-Shun Hsu. Fu-Shun Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hsu, Fu-Shun, et al.. (2024). BEING ATTACK-FREE WITH GARADACIMAB IMPROVES QUALITY OF LIFE IN PATIENTS WITH HEREDITARY ANGIOEDEMA. Annals of Allergy Asthma & Immunology. 133(6). S33–S34.
3.
4.
5.
Hsu, Fu-Shun, Chien‐Wen Huang, Chun‐Chieh Chen, et al.. (2023). A dual-purpose deep learning model for auscultated lung and tracheal sound analysis based on mixed set training. Biomedical Signal Processing and Control. 86. 105222–105222. 4 indexed citations
6.
Lin, Wei‐Chou, Kuan-Lin Kuo, Po‐Ming Chow, et al.. (2023). Anti-tumor effects of deubiquitinating enzyme inhibitor PR-619 in human chondrosarcoma through reduced cell proliferation and endoplasmic reticulum stress-related apoptosis.. PubMed. 13(7). 3055–3066. 4 indexed citations
7.
Hsu, Fu-Shun, et al.. (2022). A Progressively Expanded Database for Automated Lung Sound Analysis: An Update. Applied Sciences. 12(15). 7623–7623. 14 indexed citations
8.
Kuo, Kuan-Lin, et al.. (2021). THZ1, a covalent CDK7 inhibitor, enhances gemcitabine-induced cytotoxicity via suppression of Bcl-2 in urothelial carcinoma.. PubMed. 11(1). 171–180. 4 indexed citations
9.
Hsu, Fu-Shun, et al.. (2020). Locating stridor caused by tumor compression by using a multichannel electronic stethoscope: a case report. Journal of Clinical Monitoring and Computing. 35(3). 663–670.
10.
Hsu, Li-Chieh, et al.. (2020). Numerical Simulation for Flow of Rolling Piston Type of Rotary Compressor. Energies. 13(10). 2526–2526. 6 indexed citations
11.
12.
Hsu, Fu-Shun, et al.. (2019). Nasogastric tube decompression is unnecessary in patients undergoing laparoscopic nephroureterectomy for localized upper tract urothelial carcinoma. Journal of the Formosan Medical Association. 119(9). 1353–1359. 1 indexed citations
13.
Hsu, Fu-Shun, June‐Tai Wu, Jing‐Yi Lin, et al.. (2019). Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway. International Journal of Molecular Sciences. 20(5). 1162–1162. 23 indexed citations
14.
Liu, Cheng‐Wei, Chiao‐Chin Lee, Wen‐Yi Shau, et al.. (2019). The net clinical benefits of febuxostat versus allopurinol in patients with gout or asymptomatic hyperuricemia – A systematic review and meta-analysis. Nutrition Metabolism and Cardiovascular Diseases. 29(10). 1011–1022. 37 indexed citations
15.
Hsu, Fu-Shun, et al.. (2019). Comparison of Multipulse Laser Vaporesection versus Plasmakinetic Resection for Treatment of Benign Prostate Obstruction. Scientific Reports. 9(1). 6427–6427. 1 indexed citations
16.
Shi, Chung‐Sheng, Kuan-Lin Kuo, Po‐Ming Chow, et al.. (2019). Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study. Cells. 8(11). 1469–1469. 10 indexed citations
17.
Kuo, Kuan-Lin, Shing‐Hwa Liu, Wei‐Chou Lin, et al.. (2019). Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study. International Journal of Molecular Sciences. 20(13). 3218–3218. 24 indexed citations
18.
Lin, Wei‐Chou, Fu-Shun Hsu, Kuan-Lin Kuo, et al.. (2018). Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma. Journal of Molecular Medicine. 96(12). 1307–1318. 9 indexed citations
19.
Hsu, Fu-Shun, et al.. (2017). A Comprehensive Review of US FDA-Approved Immune Checkpoint Inhibitors in Urothelial Carcinoma. Journal of Immunology Research. 2017. 1–9. 33 indexed citations
20.
Chang, Wen‐Chang & Fu-Shun Hsu. (1992). Inhibition of platelet activation and endothelial cell injury by polyphenolic compounds isolated from Lonicera japonica Thunb. Prostaglandins Leukotrienes and Essential Fatty Acids. 45(4). 307–312. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chaoyan Wu Breakdown of academic impact, for papers by Jiayu Lv Breakdown of academic impact, for papers by Hanbin Lin Breakdown of academic impact, for papers by Zhipeng Du Breakdown of academic impact, for papers by Lin Feng Breakdown of academic impact, for papers by Xiaoqiang Geng Breakdown of academic impact, for papers by Jiang Xu
Rankless by CCL
2026